Cullinan Co-Founder Patrick Baeuerle Recognized for Contributions to Cancer Immunotherapy Cullinan Co-Founder Patrick Baeuerle Recognized for Contributions to Cancer Immunotherapy Kristen Laguerre2019-02-27T09:42:53-05:00February 27, 2019| Read More
Cullinan Oncology to Develop Novel EBNA1 Inhibitor Discovered by The Wistar Institute Cullinan Oncology to Develop Novel EBNA1 Inhibitor Discovered by The Wistar Institute Kristen Laguerre2019-02-05T18:07:53-05:00January 30, 2019| Read More
